Indexé dans
- Ouvrir la porte J
- Clés académiques
- RechercheBible
- Infrastructure nationale des connaissances en Chine (CNKI)
- Centre international pour l'agriculture et les biosciences (CABI)
- RechercheRef
- Université Hamdard
- EBSCO AZ
- OCLC - WorldCat
- CABI texte intégral
- Publions
- Fondation genevoise pour la formation et la recherche médicales
- Google Scholar
Liens utiles
Partager cette page
Dépliant de journal
Revues en libre accès
- Agriculture et aquaculture
- Alimentation et nutrition
- Biochimie
- Bioinformatique et biologie des systèmes
- Business & Management
- Chimie
- Génétique et biologie moléculaire
- Immunologie & Microbiologie
- Ingénierie
- La science des matériaux
- Neurosciences & Psychologie
- Science générale
- Sciences cliniques
- Sciences environnementales
- Sciences médicales
- Sciences pharmaceutiques
- Sciences vétérinaires
- Soins infirmiers et soins de santé
Abstrait
Mucormycosis and SARS-CoV-2 Infection- A Diagnostic and Management Challenge in Low Resource Settings
Anneth Marandu, Alex Mremi*, Tumaini Mirai, Gilbert Nkya, Patrick Amsi, Crispin Moshi, Sarah Urasa, Hilary Chipongo, Kajiru Kilonzo
Mucormycosis is currently termed as one of the mortal angioinvasive fungal diseases in the world, affecting those with diabetes mellitus, especially in acidotic states. With the current Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) pandemic, there has been a surge of mucormycosis cases being documented from Asian countries and a few from Sub-Saharan Africa. Herein, we present two cases of mucormycosis from Kilimanjaro, Tanzania, both with history of uncontrolled Diabetes mellitus type-1. One patient was confirmed to have Coronavirus disease-19 by Polymerase Chain Reaction (PCR). These are the first known documented cases of mucormycosis from Tanzania during the SARS-CoV-2 pandemic. We also have narrated on the challenges in diagnosis and management of patients with mucormycosis in our setting.